First Time Loading...

Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 40.725 USD 0.04% Market Closed
Updated: Jun 10, 2024

Amphastar Pharmaceuticals Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amphastar Pharmaceuticals Inc
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Net Income
$154.7m
CAGR 3-Years
359%
CAGR 5-Years
N/A
CAGR 10-Years
35%
Johnson & Johnson
NYSE:JNJ
Net Income
$38.5B
CAGR 3-Years
37%
CAGR 5-Years
21%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$6.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$275m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$2.3B
CAGR 3-Years
-20%
CAGR 5-Years
-23%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Net Income
$6.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
5%

See Also

What is Amphastar Pharmaceuticals Inc's Net Income?
Net Income
154.7m USD

Based on the financial report for Mar 31, 2024, Amphastar Pharmaceuticals Inc's Net Income amounts to 154.7m USD.

What is Amphastar Pharmaceuticals Inc's Net Income growth rate?
Net Income CAGR 10Y
35%

Over the last year, the Net Income growth was 66%. The average annual Net Income growth rates for Amphastar Pharmaceuticals Inc have been 359% over the past three years , and 35% over the past ten years .